Keyphrases
Operative
100%
Meta-analysis
100%
Postmenopausal Women
100%
Hormone Receptor-positive Breast Cancer
100%
Aromatase Inhibitors
100%
Risk Ratio
33%
Breast Reconstruction
16%
Objective Response Rate
16%
Surgery Rates
16%
Ultrasound
8%
Headache
8%
Clinically Significant
8%
Nausea
8%
Chemotherapy
8%
Confidence Interval
8%
Clinical Trials
8%
Inclusion Criteria
8%
Clinical Efficacy
8%
Conflicting Results
8%
Postmenopausal Patients
8%
Hot Flashes
8%
Improved Outcomes
8%
Event-based
8%
Medicine and Dentistry
Breast Cancer
100%
Meta-Analysis
100%
Postmenopause
100%
Tamoxifen
100%
Hormone Receptor
100%
Aromatase Inhibitor
100%
Quadrantectomy
25%
Clinical Trial
12%
Nausea
12%
Hot Flush
12%
Headache
12%
Chemotherapy
12%
Agricultural and Biological Sciences
Postmenopause
100%
Meta-Analysis
100%
Aromatase Inhibitor
100%
Hormone Receptor
100%
Tamoxifen
100%
Confidence Interval
12%
Headache
12%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Hormone Receptor
100%
Tamoxifen
100%
Aromatase Inhibitor
100%
Headache
12%
Nausea
12%
Chemotherapy
12%
Clinical Trial
12%
Hot Flush
12%